Psychedelic Clinical Trials in Florida: How to Find and Join Them

# Psychedelic Clinical Trials in Florida: How to Find and Join Them

If you've been reading about psychedelic therapy for depression, PTSD, or addiction and want access — right now, legally — clinical trials are the most reliable pathway. Florida has several research institutions actively conducting or recruiting for psychedelic studies.

Here's how the process actually works.

Where to find trials

ClinicalTrials.gov is the definitive database. It's run by the National Institutes of Health and lists virtually every legitimate clinical trial in the United States. You can search by condition, intervention, and location.

Search tips for psychedelic trials:

• Search "psilocybin" + "Florida" for psilocybin depression/PTSD trials
• Search "MDMA" + "PTSD" for MDMA-assisted therapy trials
• Search "ketamine" + your condition for ketamine studies (these are most numerous)
• Filter by "Recruiting" status to see only active studies

MAPS (Multidisciplinary Association for Psychedelic Studies) maintains a list of their sponsored trials at maps.org. MAPS has been the primary organization behind MDMA-assisted therapy research.

Johns Hopkins Center for Psychedelic & Consciousness Research conducts psilocybin studies and lists open studies on their website. While based in Baltimore, some studies allow remote participants for certain phases.

University of Florida and University of Miami have both been involved in psychedelic or ketamine research. Check their clinical trials registries directly.

What participation typically involves

Clinical trials for psychedelic-assisted therapy are not casual. The screening and commitment involved are substantial.

Screening (2-4 weeks): Phone screening, medical records review, physical examination, lab work, psychiatric evaluation, and detailed informed consent. Exclusion criteria are strict — personal or family history of psychotic disorders, certain cardiac conditions, current substance abuse, and some medications will disqualify you.

Preparation (1-3 sessions): If accepted, you'll meet with the study therapists before the dosing session. These preparation sessions build rapport and set expectations.

Dosing session (1 day): The actual psychedelic session. For psilocybin, this typically lasts 6-8 hours with two therapists present. For MDMA, sessions last 8-12 hours. You'll be monitored throughout.

Integration (2-6 sessions over weeks): Follow-up sessions to process the experience. This is considered essential to the therapeutic model.

Follow-up assessments (weeks to months): Questionnaires, psychiatric evaluations, and sometimes brain imaging at various time points to measure outcomes.

Total time commitment: Expect 3-6 months of involvement from screening through final follow-up.

What it costs

In most clinical trials, the treatment itself is free. The study covers the medication, therapy sessions, monitoring, and assessments. Some studies also compensate participants for their time (typically $25-$100 per visit).

You are generally responsible for your own transportation to the study site. If the site is far from your home, this can be a significant practical barrier.

Randomization and placebos

Most rigorous studies are randomized and controlled, which means:

• You may receive a placebo instead of the active compound
• You may not know which group you're in until the study ends
• Some studies use "active placebos" (like niacin or low-dose medication) that produce some noticeable effects, making it harder to guess your assignment

This is important to understand upfront. There's no guarantee you'll receive the psychedelic compound if you join a trial. But even the placebo groups receive extensive therapy, which itself has value.

What to ask before enrolling

• What are the specific inclusion and exclusion criteria?
• Will I need to stop my current medications, and for how long?
• What is the randomization ratio? (e.g., 2:1 active to placebo)
• What happens if I have a difficult experience during the session?
• Will I have access to the treatment after the study if it works for me?
• What are the known risks specific to this compound?

The reality check

Clinical trials are not a fast track to psychedelic therapy. The screening process is lengthy, many applicants are excluded, and there's a meaningful chance of receiving a placebo. The studies are designed to answer scientific questions — helping individual participants is a secondary benefit.

That said, for people with treatment-resistant conditions who have exhausted standard options, clinical trials represent legal access to promising therapies that aren't otherwise available. The medical oversight, therapeutic support, and follow-up monitoring you receive in a trial often exceeds what's available in commercial settings.

A note on "underground" options

We'd be ignoring reality not to mention that some people seek psychedelic therapy outside of clinical trials — through underground guides, retreat centers in countries where it's legal, or self-administration. As a physician, I can't recommend any of these routes. The safety infrastructure of a clinical trial — medical screening, trained therapists, emergency protocols — exists for good reason.

If you're interested in psychedelic therapy, a clinical trial is the safest and most responsible path available in Florida today.

---

This article is for educational purposes. Dr. Kim does not offer psychedelic-assisted therapy and is not affiliated with any clinical trial. For current mental health treatment, [reach out to us](/intake/mental-health).